<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Naturae</journal-id><journal-id journal-id-type="iso-abbrev">Acta Naturae</journal-id><journal-id journal-id-type="publisher-id">ActaNaturae</journal-id><journal-title-group><journal-title>Acta Naturae</journal-title></journal-title-group><issn pub-type="ppub">2075-8251</issn><publisher><publisher-name>A.I. Gordeyev</publisher-name></publisher></journal-meta><article-meta><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group><subject>Molecular Biology</subject></subj-group></subj-group></article-categories><title-group><article-title>40 Years without Smallpox</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shchelkunova</surname><given-names>G. A.</given-names></name><xref ref-type="aff" rid="AF1"/></contrib><contrib contrib-type="author"><name><surname>Shchelkunov</surname><given-names>S. N.</given-names></name><xref ref-type="aff" rid="AF1"/><xref ref-type="aff" rid="AF2"/><email>snshchel@rambler.ru, snshchel@vector.nsc.ru</email></contrib></contrib-group><aff id="AF1">State Research Center of Virology and Biotechnology VECTOR, Koltsovo, Novosibirsk region, 630559 , Russia </aff><aff id="AF2">Novosibirsk State University, Pirogov Str. 2, Novosibirsk, 630090, Russia</aff><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2017</year></pub-date><volume>9</volume><issue>4</issue><fpage>4</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &#x000ae; 2017 Park-media Ltd.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>
This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.
</license-p></license></permissions><abstract><p>
The last case of natural smallpox was recorded in October,
1977. It took humanity almost 20 years to achieve that feat after the World
Health Organization had approved the global smallpox eradication program.
Vaccination against smallpox was abolished, and, during the past 40 years, the
human population has managed to lose immunity not only to smallpox, but to
other zoonotic orthopoxvirus infections as well. As a result, multiple
outbreaks of orthopoxvirus infections in humans in several continents have been
reported over the past decades. The threat of smallpox reemergence as a result
of evolutionary transformations of these zoonotic orthopoxviruses exists.
Modern techniques for the diagnostics, prevention, and therapy of smallpox and
other orthopoxvirus infections are being developed today.
</p></abstract><kwd-group kwd-group-type="author"><kwd>smallpox</kwd><kwd>variola (smallpox) virus</kwd><kwd>evolution</kwd><kwd>DNA diagnostics</kwd><kwd>vaccine</kwd><kwd>chemotherapeutic drugs</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>
Smallpox (also known by its Latin name <italic>variola vera, </italic>derived
from <italic>varius </italic>(spotted) or <italic>varus </italic>(pimple)) got
its current name as early as the 16<sup>th</sup> century, although the disease
had been known since ancient times and had inflicted a heavier toll on humans
than many other infections and numerous wars. In the 20<sup>th</sup> century
alone, over the almost 80 years during which mass vaccination against smallpox
and an intensive anti-epidemic campaign were being conducted, 300 million
people still died as a result of the disease
[<xref rid="R1" ref-type="bibr">1</xref>].
</p><p>
In 1796, the English physician Edward Jenner proposed a method for protection
against smallpox via the inoculation of the infectious material obtained from
cows with a smallpox-like disease. This method became known as
<italic>vaccination </italic>(from the Latin <italic>vacca </italic>for cow).
This breakthrough event took place almost a century before the kingdom of
viruses was discovered
[<xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R3" ref-type="bibr">3</xref>].
</p><p>
After its introduction in 1919, mandatory smallpox vaccination in Russia (and
then, in the Soviet Union), a vast country with manifold geographic conditions
ranging from high-mountain expanses and deserts to northern tundra and
outlandish taiga areas and home to dozens of nationalities differing in
traditions, rites, and religious practices, made it possible to eliminate
smallpox morbidity by 1936 [<xref rid="R3" ref-type="bibr">3</xref>].
</p><p>
This dangerous, highly contagious disease was eradicated in many developed
countries in the first half of the 20<sup>th</sup> century. However, smallpox
outbreaks were still recorded each year in 50&#x02013;80 countries even in the
1950s. In addition, the foci of endemic smallpox in Asia, Africa, and South
America posed a constant threat of importation to countries already free of the
disease.
</p><p>
Based on an analysis of the tremendous scientific and organizational expertise
on smallpox eradication accumulated in the Soviet Union, V.M. Zhdanov suggested
initiating a worldwide program of smallpox eradication at the 9<sup>th</sup>
World Health Assembly (WHA). The corresponding resolution implying complete
smallpox eradication was adopted at the 7<sup>th</sup> WHA plenary meeting on June 12, 1958
[<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>].
</p><p>
This marked the start of an unprecedented international program of global
smallpox eradication under the aegis of the World Health Organization (WHO).
The Soviet Union not only played a key role in initiating the eradication
program, but it was also an important backer at all stages of its
implementation in subsequent years. In 1958, the year of its inception, the
Soviet Government offered 25 million doses of dry smallpox vaccines to the WHO,
which was then delivered to different countries. In 1960, a laboratory for
large-scale production of the vaccine, in compliance with the WHO requirements,
was organized at the Institute of Viral Preparations (IVP, Moscow). This
laboratory subsequently became a center where professionals from different
countries came to master smallpox vaccine manufacturing. A total of over 1.5
billion doses of the smallpox vaccine produced in the Soviet Union were used
for mass vaccination in 45 countries over 20 years of the international
smallpox eradication program. This represents one of the key roles played by
the Soviet Union in the global smallpox eradication
[<xref rid="R2" ref-type="bibr">2</xref>].
</p><p>
The Laboratory for Smallpox Prevention at the Institute of Viral Preparations
played an important role in global smallpox eradication and led to the
establishment of the International Reference Center for Smallpox. Numerous
Soviet experts were trained at the Center before visiting smallpox-endemic
countries and received the necessary preparation for practical work.
</p><p>
Thanks to the joint efforts of the world community in anti-epidemic control and
mass anti-smallpox vaccination under the Intensified Smallpox Eradication
Programme approved by WHO in 1966, the last natural case of smallpox was
recorded in Somalia in October, 1977. Based on the statement made by the Global
Commission for the Certification of Smallpox Eradication on May 8, 1980, the
33<sup>rd</sup> WHA declared that people throughout the globe had overcome
smallpox. This was the first, and yet only, victory of the world community over
a highly dangerous infectious human disease
[<xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R3" ref-type="bibr">3</xref>].
</p></sec><sec><title>THE GENOME PROJECT</title><p>
Once smallpox had been eradicated, the number of laboratories that stored a
smallpox virus named variola virus (VARV) was reduced to stave off the risk of
its accidental spread. As early as 1981, only four such laboratories remained
(in the United States, the Soviet Union, the Republic of South Africa, and the
United Kingdom) and their number was reduced to two in 1984. The latter two
laboratories, namely, the Institute of Viral Preparations (Moscow, Soviet
Union) and Centers for Disease Control and Prevention (CDC, Atlanta, United
States) got the status of WHO Collaborating Centers for Smallpox and Other
Poxvirus Infections [<xref rid="R1" ref-type="bibr">1</xref>].
</p><p>
Despite strict WHO control, these two repositories of live VARV strains were
regarded as a source of potential biological threat. Correspondingly, a
decision was made at the 4<sup>th</sup> meeting of the WHO Committee on
Orthopoxvirus Infections (Geneva, 1986) to destroy the collections of VARV
strains and their genomic DNAs. Taking into account the planned destruction of
VARV collections, it was necessary to reliably preserve the genetic material of
various VARV isolates in biologically safe form, as an issue of paramount
importance for future research. In order to preserve information about this
unique virus, the WHO Advisory Board deemed it necessary to sequence the VARV
genome [<xref rid="R4" ref-type="bibr">4</xref>].
</p><p>
Correspondingly, A.I. Kondrusev, a deputy minister of public health in the
Soviet Union, and Yu.T. Kalinin, a deputy minister of medical industry,
approved the <italic>National Program for Conservation of Genetic Material of
the Russian Collection of Variola Virus Strains </italic>with L.S.
Sandakhchiev, director general of the Scientific and Production Association
Vector (VECTOR), and O.G. Andzhaparidze, the director of IVP, as scientific
supervisors and S.N. Shchelkunov and S.S. Marennikova as principal researchers.
</p><p>
In December 1990, the 5<sup>th</sup> meeting of the WHO Committee on
Orthopoxvirus Infections approved the national programs for research into the
VARV genome proposed by Russia (VECTOR, Koltsovo, Novosibirsk region, and IVP,
Moscow) and the United States (CDC, Atlanta, Georgia, and Institute for Genomic
Research, Gaithersburg, Maryland). In May 1991, the WHO Commission inspected
the VECTOR&#x02019;s laboratory headed by S.N. Shchelkunov and officially
approved the cloning of VARV DNA fragments and their sequencing.
</p><p>
The species specific name of VARV is <italic>Variola virus. </italic>Two
subspecies are commonly distinguished: <italic>V. major, </italic>causing the
disease with a mortality rate of 5&#x02013;40% and <italic>V. minor,
</italic>with a lethal outcome of less than 2% [<xref rid="R1" ref-type="bibr">1</xref>].
VARV is a member of the genus <italic>Orthopoxvirus</italic> belonging to the family
Poxviridae. This genus also includes the zoonotic species <italic>Monkeypox
virus</italic> (MPXV), <italic>Cowpox virus</italic> (CPXV), <italic>Vaccinia
virus</italic> (VACV), <italic>Buffalopox
virus</italic> (BPXV, a subspecies of VACV), and <italic>Camelpox
virus</italic> (CMLV), all able to infect humans
[<xref rid="R2" ref-type="bibr">2</xref>-<xref rid="R4" ref-type="bibr">4</xref>].
Orthopoxviruses are closely related in their antigenic and immunological
characteristics and provide cross-protection when they infect humans or
animals [<xref rid="R1" ref-type="bibr">1</xref>].
</p><p>
By mid-1992, Russian scientists were first to successfully complete the genome
sequencing of a highly virulent VARV <italic>major </italic>strain isolated in
India in 1967 during a smallpox outbreak with a mortality rate of 31%, perform
a computer analysis of the sequencing data
[<xref rid="R13" ref-type="bibr">13</xref>-<xref rid="R16" ref-type="bibr">16</xref>], and compare
them to the then recently published genome sequence of VACV
[<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R18" ref-type="bibr">18</xref>].
The results of that work were for the first time reported
as an oral presentation at the opening the 9th International Conference on
Poxviruses and Iridoviruses [<xref rid="R19" ref-type="bibr">19</xref>]. One
year later, an American team completed the sequencing and analysis of the whole
genome of another highly virulent VARV <italic>major </italic>strain,
Bangladesh-1975, isolated during a smallpox outbreak with a mortality rate of
18.5% [<xref rid="R20" ref-type="bibr">20</xref>]. Subsequent comparison of the
genomes of these strains revealed that they were highly conserved
[<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R22" ref-type="bibr">22</xref>].
</p><p>
It was decided at the 6<sup>th</sup> Meeting of the WHO Committee on
Orthopoxvirus Infections (September 1994, Geneva, Switzerland) that the VARV
DNA stocks should be stored in two international repositories, namely, VECTOR
(by that time with the status of State Research Center of Virology and
Biotechnology) and CDC (United States).
</p><p>
The complete genome of a low virulent VARV <italic>minor</italic> strain,
Garcia-1966, was sequenced and analyzed
(<italic><xref ref-type="table" rid="T1">table</xref></italic>)
by collaborating teams from VECTOR and the CDC
[<xref rid="R23" ref-type="bibr">23</xref>].
</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table</label><caption><p>
The first sequenced orthopoxvirus genomes
</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Species</th><th rowspan="1" colspan="1">Strain</th><th rowspan="1" colspan="1">Genome size,<break/>bp</th><th rowspan="1" colspan="1">Number of<break/>potential genes</th><th rowspan="1" colspan="1">Organization which made<break/>sequencing</th><th rowspan="1" colspan="1">Year of<break/>sequencing</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Vaccinia virus</td><td align="center" rowspan="1" colspan="1">Copenhagen</td><td align="center" rowspan="1" colspan="1">191636</td><td align="center" rowspan="1" colspan="1">198</td><td align="center" rowspan="1" colspan="1">Virogenetics, USA</td><td align="center" rowspan="1" colspan="1">1990</td></tr><tr><td align="center" rowspan="1" colspan="1">Variola major virus</td><td align="center" rowspan="1" colspan="1">India-1967</td><td align="center" rowspan="1" colspan="1">185578</td><td align="center" rowspan="1" colspan="1">199</td><td align="center" rowspan="1" colspan="1">SRC VB VECTOR, Russia</td><td align="center" rowspan="1" colspan="1">1992</td></tr><tr><td align="center" rowspan="1" colspan="1">Variola major virus</td><td align="center" rowspan="1" colspan="1">Bangladesh-1975</td><td align="center" rowspan="1" colspan="1">186103</td><td align="center" rowspan="1" colspan="1">196</td><td align="center" rowspan="1" colspan="1">CDC, USA</td><td align="center" rowspan="1" colspan="1">1993</td></tr><tr><td align="center" rowspan="1" colspan="1">Variola minor virus</td><td align="center" rowspan="1" colspan="1">Garcia-1966</td><td align="center" rowspan="1" colspan="1">186986</td><td align="center" rowspan="1" colspan="1">206</td><td align="center" rowspan="1" colspan="1">SRC VB VECTOR, Russia;<break/>CDC, USA</td><td align="center" rowspan="1" colspan="1">1995</td></tr><tr><td align="center" rowspan="1" colspan="1">Cowpox virus</td><td align="center" rowspan="1" colspan="1">GRI-90</td><td align="center" rowspan="1" colspan="1">223666</td><td align="center" rowspan="1" colspan="1">212</td><td align="center" rowspan="1" colspan="1">SRC VB VECTOR, Russia</td><td align="center" rowspan="1" colspan="1">1997</td></tr><tr><td align="center" rowspan="1" colspan="1">Vaccinia virus</td><td align="center" rowspan="1" colspan="1">Ankara</td><td align="center" rowspan="1" colspan="1">177923</td><td align="center" rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1">Biomedical Research Center,<break/>Austria</td><td align="center" rowspan="1" colspan="1">1998</td></tr><tr><td align="center" rowspan="1" colspan="1">Monkeypox virus</td><td align="center" rowspan="1" colspan="1">Zaire-96-I-16</td><td align="center" rowspan="1" colspan="1">196858</td><td align="center" rowspan="1" colspan="1">191</td><td align="center" rowspan="1" colspan="1">SRC VB VECTOR, Russia</td><td align="center" rowspan="1" colspan="1">2001</td></tr><tr><td align="center" rowspan="1" colspan="1">Cowpox virus</td><td align="center" rowspan="1" colspan="1">Brighton Red</td><td align="center" rowspan="1" colspan="1">224499</td><td align="center" rowspan="1" colspan="1">218</td><td align="center" rowspan="1" colspan="1">Duke University Medical<break/>Center, USA</td><td align="center" rowspan="1" colspan="1">2002</td></tr><tr><td align="center" rowspan="1" colspan="1">Vaccinia virus</td><td align="center" rowspan="1" colspan="1">WR</td><td align="center" rowspan="1" colspan="1">194711</td><td align="center" rowspan="1" colspan="1">206</td><td align="center" rowspan="1" colspan="1">CDC, USA</td><td align="center" rowspan="1" colspan="1">2003</td></tr></tbody></table></table-wrap><p>
Taking into account the potential threat related to manipulations of live VARV
in Moscow, the collection of VARV strains was transferred from the Institute of
Viral Preparations to VECTOR (Koltsovo, Novosibirsk region) in September, 1994,
under a joint order from the Russian Ministry of Health and Medical Industry,
the Ministry of Science, the State Committee on Sanitary and Epidemiology
Surveillance, and the Academy of Medical Sciences.
</p><p>
The WHO officially registered the organization of the WHO Collaborating Center
for Orthopoxvirus Diagnosis and Repository for Variola Virus Strains and DNA at
SRC VB VECTOR in June 1997, after a WHO Commission, in 1995, had inspected the
laboratory facilities providing the highest degree of physical safety intended
for this purpose. The right of VECTOR to keep the repository of VARV strains
and their genomic DNAs was officially approved by WHA Resolution no. 49.01 and
confirmed by later Resolutions nos. 52.10, 55.15, and 60.1.
</p><p>
The WHO Advisory Committee on Variola Virus Research was organized in 1999 to
oversee manipulations with VARV and holds annual meetings for all experts
involved in relevant studies and in the development of diagnostic, prevention,
and therapeutic tools for smallpox and other human orthopoxvirus infections.
</p><p>
To gain insight into the evolutionary interactions of different orthopoxvirus
species, it became necessary to compare their genomes. The VECTOR&#x02019;s team
was the first to sequence the genome DNAs of CPXV [<xref rid="R24" ref-type="bibr">24</xref>]
and MPXV [<xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R26" ref-type="bibr">26</xref>]
isolated from sick individuals
(<italic><xref ref-type="table" rid="T1">Table</xref></italic>). The analysis of the complete
VARV, MPXV, CPXV, VACV, and CMLV genomes made it possible to establish that the CPXV DNA
is not only the longest among the studied orthopoxviruses, but also contains all the
genetic elements characteristic of the remaining orthopoxvirus species
[<xref rid="R24" ref-type="bibr">24</xref>, <xref rid="R27" ref-type="bibr">27</xref>-<xref rid="R31" ref-type="bibr">31</xref>]. VARV, MPXV, and VACV can be regarded as CPXV variants
with deletions, rearrangements, and point mutations specific to each individual species. This
suggested to us that a CPXV-like virus is the ancestor of all extant orthopoxvirus species
pathogenic for humans [<xref rid="R24" ref-type="bibr">24</xref>, <xref rid="R26" ref-type="bibr">26</xref>, <xref rid="R32" ref-type="bibr">32</xref>].
</p><p>
The accumulated data laid the basis for the pioneering comparative analysis of
the genomic strategies utilized by all orthopoxvirus species pathogenic for
humans, the first phylogenetic studies of this virus group, and the discovery
of their evolutionary relationships. However, that data has not yet allowed us
to date the molecular evolution of orthopoxviruses and, in particular, VARV
[<xref rid="R26" ref-type="bibr">26</xref>, <xref rid="R33" ref-type="bibr">33</xref>-<xref rid="R36" ref-type="bibr">36</xref>].
</p><p>
The issue of dating the VARV molecular evolution essentially shifted when the
VECTOR and CDC teams designed a method allowing one to detect genetic
differences between VARV strains. The method utilizes complete VARV genomes and
includes long-distance polymerase chain reaction (LPCR) of overlapping genomic
segments of the virus&#x02019; DNA (with a length of 10 kbp and longer) with
subsequent hydrolysis of the synthesized amplicons by frequently cutting
restriction endonucleases, electrophoresis, and a computer-aided analysis of
restriction fragment length polymorphism (RFLP). This relatively simple
approach (the LPCR&#x02013;RFLP assay), which is close to sequencing in its
information content (analyzing the positions of over 300 recognition sites for
several restriction endonucleases in a virus DNA sequence), has for the first
time made it possible to discover detailed differences between the genomes of
63 VARV strains from the Russian and U.S. collections isolated in several
geographic regions and in different years. Phylogenetic analysis of the RFLP
data for viral DNAs allowed us to pioneer the discovery that the West African
and South American VARV strains form a separate subtype (clade) that
significantly differ in their genome organization from the remaining, studied
geographic variants of VARV [<xref rid="R37" ref-type="bibr">37</xref>]. It is
essential here that the West African and South American VARV strains within the
discovered subtype form two distinct phylogenetic groups (subclades), which
suggests their independent evolution over a certain time period. The results of
this analysis and the historical facts that VARV had been several times
imported from West Africa to South America in the 16th&#x02013;18th centuries
through slaves allowed us to quantitatively estimate the rate of poxvirus
evolution for the first time [<xref rid="R38" ref-type="bibr">38</xref>].
</p><p>
Sequencing of the complete genomes of a large set of VARV strains isolated in
different years and geographic regions [<xref rid="R39" ref-type="bibr">39</xref>],
as well as extended genome segments of several additional
VARV strains [<xref rid="R40" ref-type="bibr">40</xref>], made it possible to
more precisely date the key events in VARV evolution
[<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>].
</p></sec><sec><title>POSSIBLE SMALLPOX REEMERGENCE</title><p>
Taking into account the fact that smallpox vaccination in several cases had
adverse side effects, the WHO recommended ceasing vaccination after 1980 in all
countries. The result of this decision was that mankind lost its collective
immunity not only to smallpox, but also to other zoonotic orthopoxvirus
infections. The ever more frequently recorded human cases of zoonotic
orthopoxvirus infections force us to revisit the problem of possible smallpox
reemergence resulting from a natural evolution of these viruses
[<xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R43" ref-type="bibr">43</xref>].
</p><p>
An important feature of VARV is its ability to infect only humans and the
absence of a natural reservoir (a sensitive animal species). One should keep in
mind that VARV infection of a human can in many cases (up to 40% and more)
result in a lethal outcome
[<xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R4" ref-type="bibr">4</xref>].
</p><p>
MPXV causes a human disease that resembles smallpox in its clinical
manifestations and also may result in a lethal outcome in up to 10% of cases.
The major difference between the human monkeypox and smallpox consists in a low
human-to-human transmission efficiency of the former, which so far has
prevented the development of local monkeypox outbreaks into epidemics
[<xref rid="R44" ref-type="bibr">44</xref>]. However, some recent data demonstrate
that the efficiency of MPXV spread in human populations is growing
[<xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R46" ref-type="bibr">46</xref>],
which should cause concern in both the medical
communities in Central and West Africa and at the WHO.
</p><p>
MPXV in the long-term absence of population-scale vaccination and an increased
rate of human monkeypox cases can well acquire the ability to spread from human
to human more efficiently, as is characteristic of VARV. If this happens,
mankind will face a much more complex problem as compared to smallpox
eradication. First and foremost, this will have to do with the fact that MPXV,
unlike VARV, has a natural reservoir; namely, an abundant African rodent
species [<xref rid="R32" ref-type="bibr">32</xref>].
</p><p>
Other zoonotic orthopoxvirus species typically cause sporadic human infections
(small-scale outbreaks) with a benign outcome in most cases
[<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R9" ref-type="bibr">9</xref>,
<xref rid="R12" ref-type="bibr">12</xref>]. However, it is known that human
infection with CPXV can lead to a generalized disease resembling smallpox with
a lethal outcome in immunodeficient individuals
[<xref rid="R47" ref-type="bibr">47</xref>, <xref rid="R48" ref-type="bibr">48</xref>].
</p><p>
As mentioned above, the comparative analysis of the genomes of VARV and the
zoonotic orthopoxviruses pathogenic for humans has shown that CPXV has the
largest genome containing all the genes characteristic of the remaining
orthopoxvirus species. Part of the genes in other orthopoxviruses is broken or
deleted, and individual orthopoxviruses have species-specific differences in
their set of retained genes. These data support the concept of reductive
evolution of orthopoxviruses, according to which the loss of genes plays an
important role in the evolutionary adaptation of an ancestral virus to a
certain host species, as well as in the emergence of new virus species
[<xref rid="R49" ref-type="bibr">49</xref>, <xref rid="R50" ref-type="bibr">50</xref>].
VARV, the virus most pathogenic to humans, possess the
smallest genome among all orthopoxviruses. This indicates a possibility that a
VARV-like virus can evolve from extant zoonotic orthopoxviruses with a longer
genome as a result of natural evolution
[<xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R42" ref-type="bibr">42</xref>].
</p><p>
An analysis of available archive data on smallpox epidemics, the history of
ancient civilizations, and the most recent data on the evolutionary
relationship between orthopoxviruses has allowed us to hypothesize that VARV
could have repeatedly reemerged via evolutionary changes in a zoonotic ancestor
virus and then disappeared because of an insufficient population size of
isolated ancient civilizations [<xref rid="R43" ref-type="bibr">43</xref>].
Only the historically latest smallpox pandemic raged for a long time and was
contained and stopped in the 20<sup>th</sup> century thanks to the joint
efforts of medical professionals and scientists from many countries under the
aegis of the WHO.
</p><p>
Therefore, the reemergence of smallpox or a similar human disease in the future
in the course of a natural evolution of currently existing zoonotic
orthopoxviruses is not impossible. Correspondingly, it is of utmost importance
to develop and widely adopt state-of-the-art methods for an efficient and rapid
species-specific diagnosis of all orthopoxvirus species pathogenic for humans,
including VARV. It is also important to develop new safe methods for the
prevention and therapy of human orthopoxvirus infections.
</p></sec><sec><title>SPECIES-SPECIFIC DNA DIAGNOSTICS OF ORTHOPOXVIRUSES</title><p>
The characteristics of orthopoxvirus infections are similar external
manifestations, including skin lesions; however, experience has shown that
clinical diagnosis of these diseases is frequently erroneous
[<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>].
</p><p>
The advent of the polymerase chain reaction technique has resulted in
cutting-edge methods that allow for the detection and identification of trace
amounts of microorganisms in assayed samples with a high specificity and over a
short time [<xref rid="R51" ref-type="bibr">51</xref>]. Moreover, and most
importantly, these methods require no manipulations with live specific
pathogens, including VARV and MPXV.
</p><p>
In the case of orthopoxviruses pathogenic for humans, test kits that provide
genus-specific DNA identification for an assayed virus with concurrent
species-specific differentiation are a priority. The VECTOR team was the first
to elaborate such methods based on classical multiplex PCR
[<xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R53" ref-type="bibr">53</xref>]
and multiplex real-time PCR
[<xref rid="R54" ref-type="bibr">54</xref>-<xref rid="R58" ref-type="bibr">58</xref>].
</p><p>
The method that utilizes oligonucleotide microarrays is also based on PCR; in
the assay, the synthesized DNA amplicons are identified by hybridization with
specific oligonucleotides immobilized on a support in a particular order. The
DNA preparations to be assayed in hybridization are fluorescently labeled.
After hybridization and washing, the microarray is analyzed with the help of a
laser scanner and the recorded fluorescence data for each cell of the
micromatrix are processed using specialized software. Similar to classical PCR,
this method can allow one to detect trace amounts of the analyte in a specimen.
One of the important advantages of oligonucleotide microarrays is the
possibility to simultaneously analyze a multitude of genetic loci, thereby
considerably increasing the reliability of the method
[<xref rid="R4" ref-type="bibr">4</xref>].
</p><p>
Different variants of diagnostic oligonucleotide microarrays have been designed
for species-specific diagnosis of orthopoxviruses
[<xref rid="R59" ref-type="bibr">59</xref>-<xref rid="R62" ref-type="bibr">62</xref>].
</p><p>
The development of next-generation sequencing technologies would makes it
possible to obtain the complete genome nucleotide sequence of a research
subject in short order. Genome-wide sequencing of isolated viruses in the case
of unusual orthopoxvirus infections is an ever more frequent situation
[<xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R64" ref-type="bibr">64</xref>].
These studies demonstrate that laboratory diagnostic
techniques for orthopoxvirus infections, as well as epidemiological
surveillance, need further upgrades. Naturally circulating zoonotic
orthopoxviruses pathogenic for humans require a comprehensive study and
monitoring for the emergence of new species that can potentially lead to the
emergence of new orthopoxvirus variants highly pathogenic for humans while
routine smallpox immunization is absent.
</p></sec><sec><title>MODERN ANTI-SMALLPOX VACCINES</title><p>
The first-generation smallpox vaccine was a VACV preparation produced by
propagating the virus on calf (or other animal) skin. Today, VARV vaccine
strains are produced in mammalian cell cultures and are referred to as
second-generation smallpox vaccines [<xref rid="R65" ref-type="bibr">65</xref>]. Although vaccine production in cell cultures meets
current standards, second-generation smallpox vaccines, similar to
first-generation ones, can cause adverse side effects and, thus, are of limited
use [<xref rid="R66" ref-type="bibr">66</xref>].
</p><p>
Third-generation attenuated smallpox vaccines are produced via multiple
passaging of a VACV strain in the cell culture of a heterologous host. For
example, the best studied third-generation vaccine, MVA, is produced by
multiple passages of the VACV strain Ankara in a chick fibroblast culture. The
MVA strain genome has accumulated numerous mutations and long deletions that
distinguish it from the initial VACV strain. MVA is unable to replicate in most
mammalian cells, including human cells [<xref rid="R67" ref-type="bibr">67</xref>].
</p><p>
The vaccine based on the VACV strain MVA (Imvanex/Imvamune) has undergone
numerous clinical trials, including studies in subjects with atopic dermatitis
and HIV [<xref rid="R68" ref-type="bibr">68</xref>-<xref rid="R70" ref-type="bibr">70</xref>]. This vaccine is shown to induce an antibody profile that
is similar to that induced by the conventional first-generation vaccine and to
protect various laboratory animals against zoonotic orthopoxviruses
[<xref rid="R71" ref-type="bibr">71</xref>-<xref rid="R73" ref-type="bibr">73</xref>].
Imvanex/Imvamune has been licensed in European countries, Canada, and the
United States. First and foremost, this vaccine is intended for primary
vaccination of subjects with contraindications for using first- and
second-generation smallpox vaccines.
</p><p>
Another third-generation smallpox vaccine, LC16m8, licensed in Japan, was
produced from VACV strain Lister via multiple passages in a primary rabbit
kidney cell culture at a decreased temperature (30&#x000b0;C). Clinical studies
have demonstrated a considerable reduction in the number of adverse side
effects compared to the conventional Lister-based vaccine. The resulting
attenuation of this vaccine strain is mainly due to a mutation (single
nucleotide deletion) in the <italic>B5R </italic>gene that encodes a protein
essential for extracellular enveloped virion formation [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>]. The protective
efficacy of LC16m8 in animal model experiments is comparable to that of the
parental strain Lister [<xref rid="R76" ref-type="bibr">76</xref>, <xref rid="R77" ref-type="bibr">77</xref>].
</p><p>
A new approach to the production of fourth-generation attenuated smallpox
vaccines consists in genetic engineering of variants with impaired genes that
control the host&#x02019;s protective response to virus infection, the range of
sensitive hosts, etc. by introducing targeted deletions/insertions. The best
studied variant of such VACV is strain NYVAC, with a deleted block of 12 genes
and six additional individual damaged genes. The NYVAC strain induces
considerably weaker immunity in humans as compared to the classical Lister or
Dryvax vaccine, including the inability to induce A27-specific antibodies,
which are necessary for efficient neutralization of a VACV infectious form, the
intracellular mature virus [<xref rid="R78" ref-type="bibr">78</xref>, <xref rid="R79" ref-type="bibr">79</xref>].
</p><p>
In Russia, a highly attenuated VACV variant was produced by successive
introduction of targeted deletions/insertions into five individual genes of
strain LIVP [<xref rid="R80" ref-type="bibr">80</xref>]. Additional targeted
deletion introduced into the <italic>A35R </italic>gene yielded another highly
immunogenic attenuated strain, VACdelta6 [<xref rid="R81" ref-type="bibr">81</xref>],
which is currently under preclinical trials as a fourth-generation smallpox vaccine
candidate. This vaccine can be used in combination with the smallpox DNA vaccine
[<xref rid="R82" ref-type="bibr">82</xref>].
</p></sec><sec><title>ANTI-SMALLPOX CHEMOTHERAPEUTICS</title><p>
Chemotherapeutics are no less important in the treatment of human orthopoxvirus
infections, and the search for such drugs over the past 20 years has been a
success. Since there are no adequate animal models for smallpox, potential
anti-smallpox drugs are tested in surrogate smallpox animal models [<xref rid="R83" ref-type="bibr">83</xref>]. The inhibitors of orthopoxvirus
reproduction were initially screened in cell cultures to further study the
compounds with high <italic>in vitro </italic>antiviral activity using animal
models, first and foremost, intranasal or aerosol infection of mice with CPXV
and monkeys with MPXV [<xref rid="R84" ref-type="bibr">84</xref>, <xref rid="R85" ref-type="bibr">85</xref>]. Rabbits infected with the rabbitpox virus
(RPXV) and ground squirrels infected with MPXV have recently been actively used
[<xref rid="R86" ref-type="bibr">86</xref>-<xref rid="R88" ref-type="bibr">88</xref>]. However, none of the surrogate animal models of
orthopoxvirus infection precisely reproduces human smallpox. Correspondingly,
the candidate compounds are examined in parallel, using several animal models.
</p><p>
Cidofovir, an antiviral nucleotide analog (brand name Vistide) officially
approved for clinical use against cytomegalovirus retinitis and acting as an
inhibitor of virus DNA polymerase, was the first compound intensively studied
as an anti-orthopoxvirus drug [<xref rid="R83" ref-type="bibr">83</xref>].
Cidofovir proved efficient against orthopoxvirus infections in different animal
models; however, its essential shortcomings are poor water solubility and
mandatory intravenous administration. Correspondingly, a lipid cidofovir
conjugate, CMX001 (Brincidofovir), has been synthesized [<xref rid="R86" ref-type="bibr">86</xref>, <xref rid="R89" ref-type="bibr">89</xref>]. It is a
broad-spectrum drug with pronounced anti-orthopoxvirus activity and is also
administrable in tablet form.
</p><p>
ST-246, a compound that blocks the final stage in the assembly of intracellular
enveloped virions and prevents the release of the virus from an infected cell
[<xref rid="R83" ref-type="bibr">83</xref>, <xref rid="R90" ref-type="bibr">90</xref>], is of the greatest interest. ST-246 was identified by
screening a library comprising over 350 thousand unique compounds for antiviral
activity. ST-246 (Tecovirimat) has shown low toxicity and high antiviral
efficacy in mice infected with ectromelia virus, VACV, and CPXV; rabbits
infected with RPXV and ground squirrels infected with MPXV; and monkeys
infected with MPXV or VARV [<xref rid="R90" ref-type="bibr">90</xref>-<xref rid="R92" ref-type="bibr">92</xref>]. This compound is currently undergoing
clinical trials. NIOCH-14, an analog of ST-246, also showed high activity in
different animal models of orthopoxvirus infections [<xref rid="R93" ref-type="bibr">93</xref>].
</p><p>
The search for new anti-orthopoxvirus chemotherapeutic agents with other
molecular targets is in progress [<xref rid="R90" ref-type="bibr">90</xref>,
<xref rid="R94" ref-type="bibr">94</xref>].
</p></sec><sec><title>CONCLUSIONS</title><p>
The analysis of the genome organization of orthopoxviruses pathogenic for
humans and their patterns of evolution suggest the fundamental possibility that
smallpox or a similar human disease can emerge in the future via a natural
evolution of extant zoonotic orthopoxviruses. Cessation of anti-smallpox
vaccination and the resulting loss of collective population immunity not only
to smallpox, but also to other orthopoxvirus infections creates conditions that
promote the spread of zoonotic orthopoxviruses among people, thereby
potentially enhancing the selection of virus variants highly pathogenic for
humans and epidemically dangerous. However, the situation today does not look
irredeemable and radically differs from the events far past, when man had no
control over infections. Today, most outbreaks of orthopoxvirus infections in
domestic animals and humans are registered and investigated; in addition, the
efficient international system for clinical sampling and identification of
infectious agents has been validated and anti-epidemic activities and protocols
for mass vaccination were developed during the implementation of the global
smallpox eradication program [<xref rid="R1" ref-type="bibr">1</xref>].
</p><p>
The recent efforts at the WHO are directed towards developing state-of-the-art
methods for rapid VARV identification and designing next-generation safe
anti-smallpox vaccines and chemotherapeutic agents against VARV and other
orthopoxviruses [<xref rid="R94" ref-type="bibr">94</xref>].
</p><p>
The studied vaccines and chemotherapeutics are not strictly species-specific
with respect to orthopoxviruses pathogenic for humans and, thus, are applicable
to outbreaks caused by any orthopoxvirus species. Taking into account the above
succinct information, it results that diagnostic methods should be focused on
rapid identification not only of VARV, but also of MPXV, CPXV, VACV, and CMLV
[<xref rid="R32" ref-type="bibr">32</xref>]. The recent increase in the number
of outbreaks of orthopoxvirus infections in animals and humans and the
potential danger they pose demonstrate the importance of constant monitoring of
these infections all over the world aimed at insuring against the development
of small outbreaks into epidemics and, thus, decreasing the risk of an
emergence of a new orthopoxvirus highly pathogenic for humans.
</p><p>
Phenomenal advance in synthetic biology has made it possible to <italic>de novo
</italic>synthesize the complete horsepox virus genome and obtain a live virus
[<xref rid="R95" ref-type="bibr">95</xref>]. This suggests that any
orthopoxvirus, including VARV, can be recreated in a laboratory. That is why
the development and wide clinical application of the most advanced methods for
the diagnosis, prevention, and therapy of orthopoxvirus infections pose a vital
challenge.
</p></sec></body><back><glossary><def-list><title>Abbreviations</title><def-item><term id="G01">BPXV</term><def><p>buffalopox virus</p></def></def-item><def-item><term id="G02">CMLV</term><def><p>camelpox virus</p></def></def-item><def-item><term id="G03">CPXV</term><def><p>cowpox virus</p></def></def-item><def-item><term id="G04">MPXV</term><def><p>monkeypox virus</p></def></def-item><def-item><term id="G05">PCR</term><def><p>polymerase chain reaction</p></def></def-item><def-item><term id="G06">RPXV</term><def><p>rabbitpox virus</p></def></def-item><def-item><term id="G07">VACV</term><def><p>vaccinia virus</p></def></def-item><def-item><term id="G08">VARV</term><def><p>variola virus</p></def></def-item><def-item><term id="G09">WHA</term><def><p>World Health Assembly</p></def></def-item><def-item><term id="G10">WHO</term><def><p>World Health Organization</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="report"><source>Smallpox and Its Eradication. Geneva: World Health Organization, 1988. 1460 p.</source><year>1988</year><name><surname>Fenner</surname><given-names>F.</given-names></name><name><surname>Henderson</surname><given-names>D.A.</given-names></name><name><surname>Arita</surname><given-names>I.</given-names></name><name><surname>Jezek</surname><given-names>Z.</given-names></name><name><surname>Ladnyi</surname><given-names>I.D.</given-names></name></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="book"><source>Eradication of Smallpox and Prevention of Its Recurrence. Moscow: Meditsina, 1985. 224 p.</source><year>1985</year><name><surname>Ladnyi</surname><given-names>I.D.</given-names></name></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="book"><source>Orthopoxviruses Pathogenic for Humans. Moscow: KMK Scientific Press Ltd., 1998. 386 p.</source><year>1998</year><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="book"><source>Orthopoxviruses Pathogenic for Humans. New York: Springer, 2005. 425 p.</source><year>2005</year><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Moyer</surname><given-names>R.W.</given-names></name></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><source>Lancet Infect. Dis.</source><year>2004</year><volume>4</volume><fpage>15</fpage><lpage>25</lpage><name><surname>Di Giulio</surname><given-names>D.B.</given-names></name><name><surname>Eckburg</surname><given-names>P.B.</given-names></name><pub-id pub-id-type="pmid">14720564</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><source>Vet. Microbiol.</source><year>2010</year><volume>140</volume><fpage>229</fpage><lpage>236</lpage><name><surname>Essbauer</surname><given-names>S.</given-names></name><name><surname>Pfeffer</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>H.</given-names></name><pub-id pub-id-type="pmid">19828265</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><source>Zoonoses Public Health.</source><year>2010</year><volume>57</volume><fpage>e149</fpage><lpage>155</lpage><name><surname>Bhanuprakash</surname><given-names>V.</given-names></name><name><surname>Venkatesan</surname><given-names>G.</given-names></name><name><surname>Balamurugan</surname><given-names>V.</given-names></name><name><surname>Hosamani</surname><given-names>M.</given-names></name><name><surname>Yogisharadhya</surname><given-names>R.</given-names></name><name><surname>Gandhale</surname><given-names>P.</given-names></name><name><surname>Reddy</surname><given-names>K.V.</given-names></name><name><surname>Damle</surname><given-names>A.S.</given-names></name><name><surname>Kher</surname><given-names>H.N.</given-names></name><name><surname>Chandel</surname><given-names>B.S.</given-names></name><pub-id pub-id-type="pmid">20042058</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><source>Epidemiol. Infect.</source><year>2017</year><volume>145</volume><fpage>755</fpage><lpage>759</lpage><name><surname>Popova</surname><given-names>A.Y.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Taranov</surname><given-names>O.S.</given-names></name><name><surname>Tregubchak</surname><given-names>T.V.</given-names></name><name><surname>Zaikovskaya</surname><given-names>A.V.</given-names></name><name><surname>Sergeev</surname><given-names>A.A.</given-names></name><name><surname>Vlashchenko</surname><given-names>I.V.</given-names></name><name><surname>Bodnev</surname><given-names>S.A.</given-names></name><name><surname>Ternovoi</surname><given-names>V.A.</given-names></name><name><surname>Alexandrova</surname><given-names>N.S.</given-names></name><pub-id pub-id-type="pmid">27917750</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><source>Indian J. Virol.</source><year>2012</year><volume>23</volume><fpage>1</fpage><lpage>11</lpage><name><surname>Singh</surname><given-names>R.K.</given-names></name><name><surname>Balamurugan</surname><given-names>V.</given-names></name><name><surname>Bhanuprakash</surname><given-names>V.</given-names></name><name><surname>Venkatesan</surname><given-names>G.</given-names></name><name><surname>Hosamani</surname><given-names>M.</given-names></name><pub-id pub-id-type="pmid">23729995</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>695</fpage><lpage>698</lpage><name><surname>Abrahao</surname><given-names>J.S.</given-names></name><name><surname>Campos</surname><given-names>R.K.</given-names></name><name><surname>Trindade</surname><given-names>G.S.</given-names></name><name><surname>Guimaraes da Fonseca</surname><given-names>F.</given-names></name><name><surname>Ferreira</surname><given-names>P.C.</given-names></name><name><surname>Kroon</surname><given-names>E.G.</given-names></name><pub-id pub-id-type="pmid">25811411</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><source>Vet. Microbiol.</source><year>2011</year><volume>152</volume><fpage>29</fpage><lpage>38</lpage><name><surname>Bera</surname><given-names>B.C.</given-names></name><name><surname>Shanmugasundaram</surname><given-names>K.</given-names></name><name><surname>Barua</surname><given-names>S.</given-names></name><name><surname>Venkatesan</surname><given-names>G.</given-names></name><name><surname>Virmani</surname><given-names>N.</given-names></name><name><surname>Riyesh</surname><given-names>T.</given-names></name><name><surname>Gulati</surname><given-names>B.R.</given-names></name><name><surname>Bhanuprakash</surname><given-names>V.</given-names></name><name><surname>Vaid</surname><given-names>R.K.</given-names></name><name><surname>Kakker</surname><given-names>N.K.</given-names></name><pub-id pub-id-type="pmid">21571451</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><source>Indian J. Virol.</source><year>2013</year><volume>24</volume><fpage>295</fpage><lpage>305</lpage><name><surname>Balamurugan</surname><given-names>V.</given-names></name><name><surname>Venkatesan</surname><given-names>G.</given-names></name><name><surname>Bhanuprakash</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>R.K.</given-names></name><pub-id pub-id-type="pmid">24426291</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><source>Doklady Akademii Nauk.</source><year>1991</year><volume>321</volume><fpage>402</fpage><lpage>406</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Blinov</surname><given-names>V.M.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Pozdnyakov</surname><given-names>S.G.</given-names></name><name><surname>Shelukhina</surname><given-names>E.M.</given-names></name><name><surname>Gashnikov</surname><given-names>P.V.</given-names></name></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><source>Molecular Biology.</source><year>1992</year><volume>26</volume><fpage>731</fpage><lpage>744</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Blinov</surname><given-names>V.M.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Kolikhalov</surname><given-names>A.A.</given-names></name><name><surname>Frolov</surname><given-names>I.V.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Gashnikov</surname><given-names>P.V.</given-names></name><name><surname>Belanov</surname><given-names>E.F.</given-names></name></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><source>Doklady Akademii Nauk. 1993,</source><year>1993</year><volume>328</volume><fpage>629</fpage><lpage>632</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Blinov</surname><given-names>V.M.</given-names></name><name><surname>Resenchuk</surname><given-names>S.M.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Kurmanov</surname><given-names>R.K.</given-names></name><name><surname>Sandakhchiev</surname><given-names>L.S.</given-names></name></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><source>FEBS Lett.</source><year>1993</year><volume>327</volume><fpage>321</fpage><lpage>324</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Resenchuk</surname><given-names>S.M.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Blinov</surname><given-names>V.M.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Sandakhchiev</surname><given-names>L.S.</given-names></name><pub-id pub-id-type="pmid">8394246</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><source>Virology</source><year>1990</year><volume>179</volume><fpage>247</fpage><lpage>563</lpage><name><surname>Goebel</surname><given-names>S.J.</given-names></name><name><surname>Johnson</surname><given-names>G.P.</given-names></name><name><surname>Perkus</surname><given-names>M.E.</given-names></name><name><surname>Davis</surname><given-names>S.W.</given-names></name><name><surname>Winslow</surname><given-names>J.P.</given-names></name><name><surname>Paoletti</surname><given-names>E.</given-names></name><pub-id pub-id-type="pmid">2219722</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><source>Virus Genes.</source><year>1995</year><volume>10</volume><fpage>53</fpage><lpage>71</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">7483290</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="book"><source>In: Poxviruses and Iridoviruses. Abstr. of the 9th International Conference. Les Diablerets. Switzerland, 1992</source><year>1992</year><fpage>31</fpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Marennikova</surname><given-names>S.S.</given-names></name><name><surname>Blinov</surname><given-names>V.M.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Netesov</surname><given-names>S.V.</given-names></name><name><surname>Andzhaparidze</surname><given-names>O.G.</given-names></name><name><surname>Sandakhchiev</surname><given-names>L.S.</given-names></name></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><source>Virology</source><year>1994</year><volume>201</volume><fpage>215</fpage><lpage>240</lpage><name><surname>Massung</surname><given-names>R.F.</given-names></name><name><surname>Liu</surname><given-names>L.I.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Knight</surname><given-names>J.C.</given-names></name><name><surname>Yuran</surname><given-names>T.E.</given-names></name><name><surname>Kerlavage</surname><given-names>A.R.</given-names></name><name><surname>Parsons</surname><given-names>J.M.</given-names></name><name><surname>Venter</surname><given-names>J.C.</given-names></name><name><surname>Esposito</surname><given-names>J.J.</given-names></name><pub-id pub-id-type="pmid">8184534</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><source>Virus Res.</source><year>1995</year><volume>36</volume><fpage>107</fpage><lpage>118</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Massung</surname><given-names>R.F.</given-names></name><name><surname>Esposito</surname><given-names>J.J.</given-names></name><pub-id pub-id-type="pmid">7625123</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><source>Virology</source><year>1996</year><volume>221</volume><fpage>291</fpage><lpage>300</lpage><name><surname>Massung</surname><given-names>R.F.</given-names></name><name><surname>Loparev</surname><given-names>V.N.</given-names></name><name><surname>Knight</surname><given-names>J.C.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Parsons</surname><given-names>J.M.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Esposito</surname><given-names>J.J.</given-names></name><pub-id pub-id-type="pmid">8661439</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><source>Virology</source><year>2000</year><volume>266</volume><fpage>361</fpage><lpage>386</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Loparev</surname><given-names>V.N.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Chizhikov</surname><given-names>V.E.</given-names></name><name><surname>Knight</surname><given-names>J.C.</given-names></name><name><surname>Parsons</surname><given-names>J.M.</given-names></name><name><surname>Massung</surname><given-names>R.F.</given-names></name><name><surname>Esposito</surname><given-names>J.J.</given-names></name><pub-id pub-id-type="pmid">10639322</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><source>Virology</source><year>1998</year><volume>243</volume><fpage>432</fpage><lpage>460</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Petrov</surname><given-names>N.A.</given-names></name><name><surname>Ryazankina</surname><given-names>O.I.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Kotwal</surname><given-names>G.J.</given-names></name><pub-id pub-id-type="pmid">9568042</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><source>FEBS Lett.</source><year>2001</year><volume>509</volume><fpage>66</fpage><lpage>70</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Ryazankina</surname><given-names>O.I.</given-names></name><name><surname>Petrov</surname><given-names>N.A.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Uvarova</surname><given-names>E.A.</given-names></name><name><surname>Mikheev</surname><given-names>M.V.</given-names></name><name><surname>Sisler</surname><given-names>J.R.</given-names></name><pub-id pub-id-type="pmid">11734207</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><source>Virology</source><year>2002</year><volume>297</volume><fpage>172</fpage><lpage>194</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><name><surname>Safronov</surname><given-names>P.F.</given-names></name><name><surname>Mikheev</surname><given-names>M.V.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Ryazankina</surname><given-names>O.I.</given-names></name><name><surname>Petrov</surname><given-names>N.A.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Uvarova</surname><given-names>E.A.</given-names></name><name><surname>Sandakhchiev</surname><given-names>L.S.</given-names></name><pub-id pub-id-type="pmid">12083817</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><source>Virus Genes.</source><year>1995</year><volume>9</volume><fpage>231</fpage><lpage>245</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Totmenin</surname><given-names>A.V.</given-names></name><pub-id pub-id-type="pmid">7597802</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><source>Virus Res.</source><year>2001</year><volume>81</volume><fpage>39</fpage><lpage>45</lpage><name><surname>Uvarova</surname><given-names>E.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">11682123</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><source>Virus Genes.</source><year>2002</year><volume>24</volume><fpage>157</fpage><lpage>162</lpage><name><surname>Shchelkunov</surname><given-names>S.</given-names></name><name><surname>Totmenin</surname><given-names>A.</given-names></name><name><surname>Kolosova</surname><given-names>I.</given-names></name><pub-id pub-id-type="pmid">12018707</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><source>Virus Genes.</source><year>2010</year><volume>41</volume><fpage>309</fpage><lpage>318</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">20703935</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><source>Adv. Virol.</source><year>2012</year><volume>2012</volume><elocation-id>524743</elocation-id><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">22899927</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003756</elocation-id><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">24339772</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><source>Virology Journal</source><year>2003</year><volume>77</volume><fpage>7590</fpage><lpage>7600</lpage><name><surname>Upton</surname><given-names>C.</given-names></name><name><surname>Slack</surname><given-names>S.</given-names></name><name><surname>Hunter</surname><given-names>A.L.</given-names></name><name><surname>Ehlers</surname><given-names>A.</given-names></name><name><surname>Roper</surname><given-names>R.L.</given-names></name></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><source>Proc. Natl. Acad. Sci. USA.</source><year>2003</year><volume>100</volume><fpage>15655</fpage><lpage>15660</lpage><name><surname>McLysaght</surname><given-names>A.</given-names></name><name><surname>Baldi</surname><given-names>P.F.</given-names></name><name><surname>Gaut</surname><given-names>B.S.</given-names></name><pub-id pub-id-type="pmid">14660798</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><source>J. Gen. Virol.</source><year>2004</year><volume>85</volume><fpage>105</fpage><lpage>117</lpage><name><surname>Gubser</surname><given-names>C.</given-names></name><name><surname>Hue</surname><given-names>S.</given-names></name><name><surname>Kellam</surname><given-names>P.</given-names></name><name><surname>Smith</surname><given-names>G.L.</given-names></name><pub-id pub-id-type="pmid">14718625</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><source>Intervirology.</source><year>2006</year><volume>49</volume><fpage>207</fpage><lpage>214</lpage><name><surname>Xing</surname><given-names>K.</given-names></name><name><surname>Deng</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><pub-id pub-id-type="pmid">16407658</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><source>Dokl. Biochem. Biophys.</source><year>2004</year><volume>398</volume><fpage>316</fpage><lpage>320</lpage><name><surname>Babkina</surname><given-names>I.N.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ropp</surname><given-names>S.</given-names></name><name><surname>Kline</surname><given-names>R.</given-names></name><name><surname>Damon</surname><given-names>I.</given-names></name><name><surname>Esposito</surname><given-names>J.</given-names></name><name><surname>Sandakhchiev</surname><given-names>L.S.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">15584518</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><source>Molecular Biology.</source><year>2006</year><volume>40</volume><fpage>16</fpage><lpage>19</lpage><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><source>Science.</source><year>2006</year><volume>313</volume><fpage>807</fpage><lpage>812</lpage><name><surname>Esposito</surname><given-names>J.J.</given-names></name><name><surname>Sammons</surname><given-names>S.A.</given-names></name><name><surname>Frace</surname><given-names>A.M.</given-names></name><name><surname>Osborne</surname><given-names>J.D.</given-names></name><name><surname>Olsen-Rasmussen</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Govil</surname><given-names>D.</given-names></name><name><surname>Damon</surname><given-names>I.K.</given-names></name><name><surname>Kline</surname><given-names>R.</given-names></name><name><surname>Laker</surname><given-names>M.</given-names></name><pub-id pub-id-type="pmid">16873609</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><source>Molecular Biology.</source><year>2008</year><volume>42</volume><fpage>543</fpage><lpage>555</lpage><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Nepomnyashchikh</surname><given-names>T.S.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Gutorov</surname><given-names>V.V.</given-names></name><name><surname>Babkina</surname><given-names>I.N.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><source>Russ. J. Genet.</source><year>2008</year><volume>44</volume><fpage>895</fpage><lpage>908</lpage><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><source>Arch. Virol.</source><year>2009</year><volume>154</volume><fpage>1865</fpage><lpage>1871</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">19882103</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2011</year><volume>29S</volume><fpage>D49</fpage><lpage>53</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><source>Emerg. Infect.</source><year>2000</year><volume>4</volume><fpage>45</fpage><lpage>67</lpage><name><surname>Breman</surname><given-names>J.G.</given-names></name></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><source>Proc. Natl. Acad. Sci. USA.</source><year>2010</year><volume>107</volume><fpage>16262</fpage><lpage>16267</lpage><name><surname>Rimoin</surname><given-names>A.W.</given-names></name><name><surname>Mulembakani</surname><given-names>P.M.</given-names></name><name><surname>Johnston</surname><given-names>S.C.</given-names></name><name><surname>Lloyd Smith</surname><given-names>J.O.</given-names></name><name><surname>Kisalu</surname><given-names>N.K.</given-names></name><name><surname>Kinkela</surname><given-names>T.L.</given-names></name><name><surname>Blumberg</surname><given-names>S.</given-names></name><name><surname>Thomassen</surname><given-names>H.A.</given-names></name><name><surname>Pike</surname><given-names>B.L.</given-names></name><name><surname>Fair</surname><given-names>J.N.</given-names></name><pub-id pub-id-type="pmid">20805472</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><source>Curr. Opin. Virol.</source><year>2012</year><volume>2</volume><fpage>335</fpage><lpage>343</lpage><name><surname>Reynolds</surname><given-names>M.G.</given-names></name><name><surname>Carroll</surname><given-names>D.S.</given-names></name><name><surname>Karem</surname><given-names>K.L.</given-names></name><pub-id pub-id-type="pmid">22709519</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><source>J. Vet. Med.</source><year>1991</year><volume>1338</volume><fpage>421</fpage><lpage>431</lpage><name><surname>Czerny</surname><given-names>C.P.</given-names></name><name><surname>Eis-Hubinger</surname><given-names>A.M.</given-names></name><name><surname>Mayr</surname><given-names>A.</given-names></name><name><surname>Schneweis</surname><given-names>K.E.</given-names></name><name><surname>Pfeiff</surname><given-names>B.</given-names></name></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><source>Emerg. Infect. Dis.</source><year>2016</year><volume>22</volume><fpage>553</fpage><lpage>555</lpage><name><surname>Fassbender</surname><given-names>P.</given-names></name><name><surname>Zange</surname><given-names>S.</given-names></name><name><surname>Ibrahim</surname><given-names>S.</given-names></name><name><surname>Zoeller</surname><given-names>G.</given-names></name><name><surname>Herbstreit</surname><given-names>F.</given-names></name><name><surname>Meyer</surname><given-names>H.</given-names></name><pub-id pub-id-type="pmid">26891134</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><source>Viruses.</source><year>2010</year><volume>2</volume><fpage>1933</fpage><lpage>1967</lpage><name><surname>Hendrickson</surname><given-names>R.C.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Hatcher</surname><given-names>E.L.</given-names></name><name><surname>Lefkowitz</surname><given-names>E.J.</given-names></name><pub-id pub-id-type="pmid">21994715</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><source>Virus Genes.</source><year>2011</year><volume>42</volume><fpage>171</fpage><lpage>177</lpage><name><surname>Coulson</surname><given-names>D.</given-names></name><name><surname>Upton</surname><given-names>C.</given-names></name><pub-id pub-id-type="pmid">21153876</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><source>Meth. Enzymol.</source><year>1987</year><volume>155</volume><fpage>335</fpage><lpage>350</lpage><name><surname>Mullis</surname><given-names>K.B.</given-names></name><name><surname>Faloona</surname><given-names>F.</given-names></name><pub-id pub-id-type="pmid">3431465</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><source>Molekular. Genet. Microbiol. Virusol.</source><year>2003</year><issue>1</issue><fpage>45</fpage><lpage>52</lpage><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><source>Mol. Cell. Probes.</source><year>2005</year><volume>19</volume><fpage>1</fpage><lpage>8</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><pub-id pub-id-type="pmid">15652214</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><source>J. Clin. Microbiol.</source><year>2004</year><volume>42</volume><fpage>1940</fpage><lpage>1946</lpage><name><surname>Olson</surname><given-names>V.A.</given-names></name><name><surname>Laue</surname><given-names>T.</given-names></name><name><surname>Laker</surname><given-names>M.T.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Niedrig</surname><given-names>M.</given-names></name><name><surname>Damon</surname><given-names>I.K.</given-names></name><name><surname>Meyer</surname><given-names>H.</given-names></name><pub-id pub-id-type="pmid">15131152</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><source>Vopr. Virusol.</source><year>2009</year><volume>54</volume><fpage>28</fpage><lpage>33</lpage><name><surname>Kostina</surname><given-names>E.V.</given-names></name><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name><name><surname>Ryabinin</surname><given-names>V.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Sinyakov</surname><given-names>A.N.</given-names></name></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><source>J. Virol. Meth.</source><year>2011</year><volume>175</volume><fpage>163</fpage><lpage>169</lpage><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Shcherbakov</surname><given-names>D.N.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><source>Klinich. Laborat. Diagnost.</source><year>2011</year><issue>12</issue><fpage>39</fpage><lpage>42</lpage><name><surname>Shcherbakov</surname><given-names>D.N.</given-names></name><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><source>J. Virol. Methods.</source><year>2016</year><volume>236</volume><fpage>215</fpage><lpage>220</lpage><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Gavrilova</surname><given-names>E.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">27477914</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><source>J. Clin. Microbiol.</source><year>2002</year><volume>40</volume><fpage>753</fpage><lpage>757</lpage><name><surname>Lapa</surname><given-names>S.</given-names></name><name><surname>Mikheev</surname><given-names>M.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.</given-names></name><name><surname>Mikhailovich</surname><given-names>V.</given-names></name><name><surname>Sobolev</surname><given-names>A.</given-names></name><name><surname>Blinov</surname><given-names>V.</given-names></name><name><surname>Babkin</surname><given-names>I.</given-names></name><name><surname>Guskov</surname><given-names>A.</given-names></name><name><surname>Sokunova</surname><given-names>E.</given-names></name><name><surname>Zasedatelev</surname><given-names>A.</given-names></name><pub-id pub-id-type="pmid">11880388</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><source>Vopr. Virusol.</source><year>2003</year><volume>48</volume><fpage>4</fpage><lpage>9</lpage><name><surname>Mikheev</surname><given-names>M.V.</given-names></name><name><surname>Lapa</surname><given-names>S.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Chikova</surname><given-names>A.K.</given-names></name><name><surname>Mikhailovich</surname><given-names>M.V.</given-names></name><name><surname>Sobolev</surname><given-names>A.Y.</given-names></name><name><surname>Babkin</surname><given-names>I.V.</given-names></name><name><surname>Gryadunov</surname><given-names>D.A.</given-names></name><name><surname>Bulavkina</surname><given-names>M.A.</given-names></name><name><surname>Guskov</surname><given-names>A.A.</given-names></name></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><source>J. Virol. Methods.</source><year>2003</year><volume>112</volume><fpage>67</fpage><lpage>78</lpage><name><surname>Laassri</surname><given-names>M.</given-names></name><name><surname>Chizhikov</surname><given-names>V.</given-names></name><name><surname>Mikheev</surname><given-names>M.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.</given-names></name><name><surname>Chumakov</surname><given-names>K.</given-names></name><pub-id pub-id-type="pmid">12951214</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><source>J. Med. Virol.</source><year>2006</year><volume>78</volume><fpage>1325</fpage><lpage>1340</lpage><name><surname>Ryabinin</surname><given-names>V.A.</given-names></name><name><surname>Shundrin</surname><given-names>L.A.</given-names></name><name><surname>Kostina</surname><given-names>E.B.</given-names></name><name><surname>Laassri</surname><given-names>M.</given-names></name><name><surname>Chizhikov</surname><given-names>V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><name><surname>Chumakov</surname><given-names>K.</given-names></name><name><surname>Sinyakov</surname><given-names>A.N.</given-names></name><pub-id pub-id-type="pmid">16927285</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><source>Genome Announc.</source><year>2014</year><volume>2</volume><elocation-id>e01086&#x02013;13</elocation-id><name><surname>Mavian</surname><given-names>C.</given-names></name><name><surname>Lopez-Bueno</surname><given-names>A.</given-names></name><name><surname>Alcami</surname><given-names>A.</given-names></name><pub-id pub-id-type="pmid">24407630</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><source>N. Engl. J. Med.</source><year>2015</year><volume>372</volume><fpage>1223</fpage><lpage>1230</lpage><name><surname>Vora</surname><given-names>N.M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Geleishvili</surname><given-names>M.</given-names></name><name><surname>Emerson</surname><given-names>G.L.</given-names></name><name><surname>Khmaladze</surname><given-names>E.</given-names></name><name><surname>Maghlakelidze</surname><given-names>G.</given-names></name><name><surname>Navdarashvili</surname><given-names>A.</given-names></name><name><surname>Zakhashvili</surname><given-names>K.</given-names></name><name><surname>Kokhreidze</surname><given-names>M.</given-names></name><name><surname>Endeladze</surname><given-names>M.</given-names></name><pub-id pub-id-type="pmid">25806914</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><source>Viruses.</source><year>2015</year><volume>7</volume><fpage>1726</fpage><lpage>1803</lpage><name><surname>Sanchez-Sampedro</surname><given-names>L.</given-names></name><name><surname>Perdiguero</surname><given-names>B.</given-names></name><name><surname>Mejias-Perez</surname><given-names>E.</given-names></name><name><surname>Garcia-Arriaza</surname><given-names>J.</given-names></name><name><surname>Di Pilato</surname><given-names>M.</given-names></name><name><surname>Esteban</surname><given-names>M.</given-names></name><pub-id pub-id-type="pmid">25853483</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2009</year><volume>10</volume><fpage>1637</fpage><lpage>1644</lpage><name><surname>Frey</surname><given-names>S.E.</given-names></name><name><surname>Newman</surname><given-names>F.K.</given-names></name><name><surname>Kennedy</surname><given-names>J.S.</given-names></name><name><surname>Ennis</surname><given-names>F.</given-names></name><name><surname>Abate</surname><given-names>G.</given-names></name><name><surname>Hoft</surname><given-names>D.F.</given-names></name><name><surname>Monath</surname><given-names>T.P.</given-names></name></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><source>J. Gen. Virol.</source><year>1991</year><volume>72</volume><fpage>1031</fpage><lpage>1038</lpage><name><surname>Meyer</surname><given-names>H.</given-names></name><name><surname>Sutter</surname><given-names>G.</given-names></name><name><surname>Mayr</surname><given-names>A.</given-names></name><pub-id pub-id-type="pmid">2033387</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2014</year><volume>32</volume><fpage>5696</fpage><lpage>5702</lpage><name><surname>Sonnenburg</surname><given-names>F.</given-names></name><name><surname>Perona</surname><given-names>P.</given-names></name><name><surname>Darsow</surname><given-names>U.</given-names></name><name><surname>Ring</surname><given-names>J.</given-names></name><name><surname>von Krempelhuber</surname><given-names>A.</given-names></name><name><surname>Vollmar</surname><given-names>J.</given-names></name><name><surname>Roesch</surname><given-names>S.</given-names></name><name><surname>Baedeker</surname><given-names>N.</given-names></name><name><surname>Kollaritsch</surname><given-names>H.</given-names></name><name><surname>Chaplin</surname><given-names>P.</given-names></name><pub-id pub-id-type="pmid">25149431</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><source>PLoS One.</source><year>2015</year><volume>10</volume><elocation-id>e0122653</elocation-id><name><surname>Zitzmann-Roth</surname><given-names>E.M.</given-names></name><name><surname>von Sonnenburg</surname><given-names>F.</given-names></name><name><surname>de la Motte</surname><given-names>S.</given-names></name><name><surname>Arndtz-Wiedemann</surname><given-names>N.</given-names></name><name><surname>von Krempelhuber</surname><given-names>A.</given-names></name><name><surname>Uebler</surname><given-names>N.</given-names></name><name><surname>Vollmar</surname><given-names>J.</given-names></name><name><surname>Virgin</surname><given-names>G.</given-names></name><name><surname>Chaplin</surname><given-names>P.</given-names></name><pub-id pub-id-type="pmid">25879867</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><source>PLoS One.</source><year>2016</year><volume>11</volume><elocation-id>e0157335</elocation-id><name><surname>Greenberg</surname><given-names>R.N.</given-names></name><name><surname>Hay</surname><given-names>C.M.</given-names></name><name><surname>Stapleton</surname><given-names>J.T.</given-names></name><name><surname>Marbury</surname><given-names>T.C.</given-names></name><name><surname>Wagner</surname><given-names>E.</given-names></name><name><surname>Kreitmeir</surname><given-names>E.</given-names></name><name><surname>Roesch</surname><given-names>S.</given-names></name><name><surname>von Krempelhuber</surname><given-names>A.</given-names></name><name><surname>Young</surname><given-names>P.</given-names></name><name><surname>Nichols</surname><given-names>R.</given-names></name><pub-id pub-id-type="pmid">27327616</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><source>Nature</source><year>2004</year><volume>428</volume><fpage>182</fpage><lpage>185</lpage><name><surname>Earl</surname><given-names>P.L.</given-names></name><name><surname>Americo</surname><given-names>J.L.</given-names></name><name><surname>Wyatt</surname><given-names>L.S.</given-names></name><name><surname>Eller</surname><given-names>L.A.</given-names></name><name><surname>Whitbeck</surname><given-names>J.C.</given-names></name><name><surname>Cohen</surname><given-names>G.H.</given-names></name><name><surname>Eisenberg</surname><given-names>R.J.</given-names></name><name><surname>Hartmann</surname><given-names>C.J.</given-names></name><name><surname>Jackson</surname><given-names>D.L.</given-names></name><name><surname>Kulesh</surname><given-names>D.A.</given-names></name><pub-id pub-id-type="pmid">15014500</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><source>Clin. Vaccine Immunol.</source><year>2016</year><volume>23</volume><fpage>648</fpage><lpage>651</lpage><name><surname>Jones</surname><given-names>D.I.</given-names></name><name><surname>McGee</surname><given-names>C.E.</given-names></name><name><surname>Sample</surname><given-names>C.J.</given-names></name><name><surname>Sempowski</surname><given-names>G.D.</given-names></name><name><surname>Pickup</surname><given-names>D.J.</given-names></name><name><surname>Staats</surname><given-names>H.F.</given-names></name><pub-id pub-id-type="pmid">27146001</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><source>Adv. Virus Res.</source><year>2017</year><volume>97</volume><fpage>187</fpage><lpage>243</lpage><name><surname>Volz</surname><given-names>A.</given-names></name><name><surname>Sutter</surname><given-names>G.</given-names></name><pub-id pub-id-type="pmid">28057259</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><source>Proc. Natl. Acad. Sci. USA.</source><year>2005</year><volume>102</volume><fpage>4152</fpage><lpage>4157</lpage><name><surname>Kidokoro</surname><given-names>M.</given-names></name><name><surname>Tashiro</surname><given-names>M.</given-names></name><name><surname>Shida</surname><given-names>H.</given-names></name><pub-id pub-id-type="pmid">15753319</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2015</year><volume>33</volume><fpage>6106</fpage><lpage>6111</lpage><name><surname>Eto</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><name><surname>Yokote</surname><given-names>H.</given-names></name><name><surname>Kurane</surname><given-names>I.</given-names></name><name><surname>Kanatani</surname><given-names>Y.</given-names></name><pub-id pub-id-type="pmid">26319072</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2006</year><volume>24</volume><fpage>3686</fpage><lpage>3694</lpage><name><surname>Empig</surname><given-names>C.</given-names></name><name><surname>Kenner</surname><given-names>J.R.</given-names></name><name><surname>Perret-Gentil</surname><given-names>M.</given-names></name><name><surname>Youree</surname><given-names>B.E.</given-names></name><name><surname>Bell</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>A.</given-names></name><name><surname>Gurwith</surname><given-names>M.</given-names></name><name><surname>Higgins</surname><given-names>K.</given-names></name><name><surname>Lock</surname><given-names>M.</given-names></name><name><surname>Rice</surname><given-names>A.D.</given-names></name><pub-id pub-id-type="pmid">16430997</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><source>Vaccine.</source><year>2015</year><volume>33</volume><fpage>6112</fpage><lpage>6119</lpage><name><surname>Yokote</surname><given-names>H.</given-names></name><name><surname>Shinmura</surname><given-names>Y.</given-names></name><name><surname>Kanehara</surname><given-names>T.</given-names></name><name><surname>Maruno</surname><given-names>S.</given-names></name><name><surname>Kuranaga</surname><given-names>M.</given-names></name><name><surname>Matsui</surname><given-names>H.</given-names></name><name><surname>Hashizume</surname><given-names>S.</given-names></name><pub-id pub-id-type="pmid">26241947</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><source>Virology</source><year>1992</year><volume>188</volume><fpage>217</fpage><lpage>232</lpage><name><surname>Tartaglia</surname><given-names>J.</given-names></name><name><surname>Perkus</surname><given-names>M.E.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name><name><surname>Norton</surname><given-names>E.K.</given-names></name><name><surname>Audonnet</surname><given-names>J.C.</given-names></name><name><surname>Cox</surname><given-names>W.I.</given-names></name><name><surname>Davis</surname><given-names>S.W.</given-names></name><name><surname>van der Hoeven</surname><given-names>J.</given-names></name><name><surname>Meignier</surname><given-names>B.</given-names></name><name><surname>Riviere</surname><given-names>M.</given-names></name><pub-id pub-id-type="pmid">1566575</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><source>J. Gen. Virol.</source><year>2008</year><volume>89</volume><fpage>2992</fpage><lpage>2997</lpage><name><surname>Midgley</surname><given-names>C.M.</given-names></name><name><surname>Putz</surname><given-names>M.M.</given-names></name><name><surname>Weber</surname><given-names>J.N.</given-names></name><name><surname>Smith</surname><given-names>G.L.</given-names></name><pub-id pub-id-type="pmid">19008384</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><source>Acta Naturae.</source><year>2015</year><volume>7</volume><fpage>113</fpage><lpage>121</lpage><name><surname>Yakubitskiy</surname><given-names>S.N.</given-names></name><name><surname>Kolosova</surname><given-names>I.V.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><source>Dokl. Biochem. Biophys.</source><year>2016</year><volume>466</volume><fpage>35</fpage><lpage>38</lpage><name><surname>Yakubitskiy</surname><given-names>S.N.</given-names></name><name><surname>Kolosova</surname><given-names>I.V.</given-names></name><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name><pub-id pub-id-type="pmid">27025484</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><source>Acta Naturae.</source><year>2017</year><volume>9</volume><fpage>88</fpage><lpage>93</lpage><name><surname>Maksyutov</surname><given-names>R.A.</given-names></name><name><surname>Yakubitskiy</surname><given-names>S.N.</given-names></name><name><surname>Kolosova</surname><given-names>I.V.</given-names></name><name><surname>Shchelkunov</surname><given-names>S.N.</given-names></name></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><source>Antivir. Chem. Chemother.</source><year>2008</year><volume>19</volume><fpage>115</fpage><lpage>124</lpage><name><surname>Smee</surname><given-names>D.F.</given-names></name><pub-id pub-id-type="pmid">19024628</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><source>J. Infect. Dis.</source><year>2000</year><volume>181</volume><fpage>10</fpage><lpage>19</lpage><name><surname>Bray</surname><given-names>M.</given-names></name><name><surname>Martinez</surname><given-names>M.</given-names></name><name><surname>Smee</surname><given-names>D.F.</given-names></name><name><surname>Kefauer</surname><given-names>D.</given-names></name><name><surname>Thompson</surname><given-names>E.</given-names></name><name><surname>Huggins</surname><given-names>J.W.</given-names></name><pub-id pub-id-type="pmid">10608745</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><source>Lab. Invest.</source><year>2001</year><volume>81</volume><fpage>1581</fpage><lpage>1600</lpage><name><surname>Zaucha</surname><given-names>G.M.</given-names></name><name><surname>Jahrling</surname><given-names>P.B.</given-names></name><name><surname>Geisbert</surname><given-names>T.W.</given-names></name><name><surname>Swearengen</surname><given-names>J.R.</given-names></name><name><surname>Hensley</surname><given-names>L.</given-names></name><pub-id pub-id-type="pmid">11742030</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><source>Viruses.</source><year>2011</year><volume>3</volume><fpage>47</fpage><lpage>62</lpage><name><surname>Rice</surname><given-names>A.D.</given-names></name><name><surname>Adams</surname><given-names>M.M.</given-names></name><name><surname>Wallace</surname><given-names>G.</given-names></name><name><surname>Burrage</surname><given-names>A.M.</given-names></name><name><surname>Lindsey</surname><given-names>S.F.</given-names></name><name><surname>Smith</surname><given-names>A.J.</given-names></name><name><surname>Swetnam</surname><given-names>D.</given-names></name><name><surname>Manning</surname><given-names>B.R.</given-names></name><name><surname>Gray</surname><given-names>S.A.</given-names></name><name><surname>Lambert</surname><given-names>B.</given-names></name><pub-id pub-id-type="pmid">21373379</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><source>Am. J. Trop. Med. Hyg.</source><year>2007</year><volume>76</volume><fpage>768</fpage><lpage>773</lpage><name><surname>Sbrana</surname><given-names>E.</given-names></name><name><surname>Jordan</surname><given-names>R.</given-names></name><name><surname>Hruby</surname><given-names>D.E.</given-names></name><name><surname>Mateo</surname><given-names>R.I.</given-names></name><name><surname>Xiao</surname><given-names>S.Y.</given-names></name><name><surname>Siirin</surname><given-names>M.</given-names></name><name><surname>Newman</surname><given-names>P.C.</given-names></name><name><surname>Da Rosa</surname><given-names>A.P.</given-names></name><name><surname>Tesh</surname><given-names>R.B.</given-names></name><pub-id pub-id-type="pmid">17426185</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><source>Transbound. Emerg. Dis.</source><year>2017</year><volume>64</volume><fpage>226</fpage><lpage>236</lpage><name><surname>Sergeev</surname><given-names>A.A.</given-names></name><name><surname>Kabanov</surname><given-names>A.S.</given-names></name><name><surname>Bulychev</surname><given-names>L.E.</given-names></name><name><surname>Sergeev</surname><given-names>A.A.</given-names></name><name><surname>Pyankov</surname><given-names>O.V.</given-names></name><name><surname>Bodnev</surname><given-names>S.A.</given-names></name><name><surname>Galahova</surname><given-names>D.O.</given-names></name><name><surname>Zamedyanskaya</surname><given-names>A.S.</given-names></name><name><surname>Titova</surname><given-names>K.A.</given-names></name><name><surname>Glotova</surname><given-names>T.I.</given-names></name><pub-id pub-id-type="pmid">25944444</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><source>Antiviral Res.</source><year>2014</year><volume>111</volume><fpage>42</fpage><lpage>52</lpage><name><surname>Parker</surname><given-names>S.</given-names></name><name><surname>Crump</surname><given-names>R.</given-names></name><name><surname>Foster</surname><given-names>S.</given-names></name><name><surname>Hartzler</surname><given-names>H.</given-names></name><name><surname>Hembrador</surname><given-names>E.</given-names></name><name><surname>Lanier</surname><given-names>E.R.</given-names></name><name><surname>Painter</surname><given-names>G.</given-names></name><name><surname>Schriewer</surname><given-names>J.</given-names></name><name><surname>Trost</surname><given-names>L.C.</given-names></name><name><surname>Buller</surname><given-names>R.M.</given-names></name><pub-id pub-id-type="pmid">25128688</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><source>Future Virol.</source><year>2013</year><volume>8</volume><fpage>891</fpage><lpage>901</lpage><name><surname>Smee</surname><given-names>D.F.</given-names></name><pub-id pub-id-type="pmid">24563659</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><source>Antimicrob. Agents Chemother.</source><year>2013</year><volume>57</volume><fpage>6246</fpage><lpage>6253</lpage><name><surname>Mucker</surname><given-names>E.M.</given-names></name><name><surname>Goff</surname><given-names>A.J.</given-names></name><name><surname>Shamblin</surname><given-names>J.D.</given-names></name><name><surname>Grosenbach</surname><given-names>D.W.</given-names></name><name><surname>Damon</surname><given-names>I.K.</given-names></name><name><surname>Mehal</surname><given-names>J.M.</given-names></name><name><surname>Holman</surname><given-names>R.C.</given-names></name><name><surname>Carroll</surname><given-names>D.</given-names></name><name><surname>Gallardo</surname><given-names>N.</given-names></name><name><surname>Olson</surname><given-names>V.A.</given-names></name><pub-id pub-id-type="pmid">24100494</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><source>Antimicrob. Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>4296</fpage><lpage>4300</lpage><name><surname>Berhanu</surname><given-names>A.</given-names></name><name><surname>Prigge</surname><given-names>J.T.</given-names></name><name><surname>Silvera</surname><given-names>P.M.</given-names></name><name><surname>Honeychurch</surname><given-names>K.M.</given-names></name><name><surname>Hruby</surname><given-names>D.E.</given-names></name><name><surname>Grosenbach</surname><given-names>D.W.</given-names></name><pub-id pub-id-type="pmid">25896687</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><source>J. Gen. Virol.</source><year>2016</year><volume>97</volume><fpage>1229</fpage><lpage>1239</lpage><name><surname>Mazurkov</surname><given-names>O.Y.</given-names></name><name><surname>Kabanov</surname><given-names>A.S.</given-names></name><name><surname>Shishkina</surname><given-names>L.N.</given-names></name><name><surname>Sergeev</surname><given-names>A.A.</given-names></name><name><surname>Skarnovich</surname><given-names>M.O.</given-names></name><name><surname>Bormotov</surname><given-names>N.I.</given-names></name><name><surname>Skarnovich</surname><given-names>M.A.</given-names></name><name><surname>Ovchinnikova</surname><given-names>A.S.</given-names></name><name><surname>Titova</surname><given-names>K.A.</given-names></name><name><surname>Galahova</surname><given-names>D.O.</given-names></name><pub-id pub-id-type="pmid">26861777</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="report"><source>Scientific Review of Variola Virus Research, 1999-2010. Geneva: World Health Organization, 2010. 128 p.</source><year>2010</year></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="report"><source>WHO Advisory Committee on Variola Virus Research: Report of the Eighteenth Meeting. Geneva: World Health Organization, 2017. 58 p.</source><year>2017</year></element-citation></ref></ref-list></back></article>